Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Feb 27:8:86.
doi: 10.1186/1743-422X-8-86.

Revised cutoff values of ALT and HBV DNA level can better differentiate HBeAg (-) chronic inactive HBV patients from active carriers

Bushra Ijaz  1 , Waqar Ahmad, Fouzia T Javed, Sana Gull, Sajida Hassan
Affiliations

Revised cutoff values of ALT and HBV DNA level can better differentiate HBeAg (-) chronic inactive HBV patients from active carriers

Bushra Ijaz et al. Virol J. .

Abstract

Background and aims: ELISA is still used as primary test for diagnosis HBV disease. However, ELISA-positive patients were marked as HBV inactive after confirmation with PCR and vice versa. Our aim was to assess the performance of new cut-off value of ALT, HBV DNA load and significance of AST as screening tool for HBeAg (-) chronic active or inactive patients in Pakistani population.

Materials and methods: In a cross-sectional, cohort study, 567 HBeAg (-) patients followed for one year were selected. Patients with persistent elevated ALT than normal and HBV DNA ≥ 100,000 copies/mL were taken as active chronic. Diagnostic values for ALT, AST and HBV DNA load in HBV HBeAg (-) chronic active and inactive patients compared using receiver operation characteristic (ROC) curves.

Results: Of 567 HBeAg (-) patients, 228 were classified as chronic inactive and 339 as active. HBV infection was dominant in male. Serum ALT, AST and HBV DNA levels showed significant and high AUROC to differentiate chronic HBeAg (-) inactive patients from active. AUROC for Serum ALT, AST and HBV DNA were observed 0.997, 0.969 and 1.000, respectively. For revised cut off value for ALT (30 IU/L for male and 19 IU/L for female) and HBV DNA load ≥100,000 copies/mL, a PPV of 97%, NPV of 94%, a sensitivity of 98%, and a specificity of 92% was observed to discriminate active carriers from inactive carriers. We also observed 93.5% specificity, 83.1% sensitivity, 82% PPV and 89.5% NPV for AST ≤20 IU/L to differentiate inactive carriers from active ones in our study group.

Conclusions: Revised cut off value of ALT and NIH derived HBV DNA value can better discriminate between HBeAg (-) chronic active and inactive patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
ROC curve of serum ALT, AST and HBV DNA levels for HBeAg (-) patients showed serum ALT, AST and HBV levels could better predict HBV chronic active carriers at given cutoff value .
Figure 2
Figure 2
Correlation of ALT and AST with HBV DNA levels in HBeAg chronic inactive and active patients . A and C: association between ALT and AST with HBV DNA levels in chronic inactive carriers; B and D: association between ALT and AST with HBV DNA levels in chronic active carriers.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Narahari S, Juwle A, Basak S, Saranath D. Prevalence and geographic distribution of Hepatitis C Virus genotypes in Indian patient cohort. Infect Genet Evol. 2009;9:643–645. doi: 10.1016/j.meegid.2009.04.001. - DOI - PubMed
    1. Ono-Nita SK, Carrilho FJ, Cardoso RA, Nita ME, da Silva LC. Searching for chronic hepatitis B patients in a low prevalence area--role of racial origin. BMC Fam Pract. 2004;5:7. doi: 10.1186/1471-2296-5-7. - DOI - PMC - PubMed
    1. Buti M, Sanchez F, Cotrina M, Jardi R, Rodriguez F, Esteban R, Guardia J. Quantitative hepatitis B virus DNA testing for the early prediction of the maintenance of response during lamivudine therapy in patients with chronic hepatitis B. J Infect Dis. 2001;183:1277–1280. doi: 10.1086/319677. - DOI - PubMed
    1. Kessler HH, Preininger S, Stelzl E, Daghofer E, Santner BI, Marth E, Lackner H, Stauber RE. Identification of different states of hepatitis B virus infection with a quantitative PCR assay. Clin Diagn Lab Immunol. 2000;7:298–300. - PMC - PubMed
    1. Zoulim F. Quantification and genotyping in management of chronic hepatitis B and C. Virus Res. 2002;82:45–52. doi: 10.1016/S0168-1702(01)00386-0. - DOI - PubMed

Publication types